Trial Profile
Vitiligo induction and therapy model: clinical and immunological analysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2019
Price :
$35
*
At a glance
- Drugs Mometasone (Primary) ; Pimecrolimus (Primary) ; Tacrolimus (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 02 Apr 2019 Status changed from recruiting to completed.
- 12 Sep 2014 New trial record